EF Hutton Assumes Trxade Health at Buy, Announces Price Target of $1.25
BenzingaJun 1, 2023 04:46 ET
Maxim Adjusts Price Target on Trxade Health to $1.75 From $2.50, Maintains Buy Rating
MT NewswiresMar 28, 2023 10:23 ET
Maxim Group Maintains Buy on Trxade Health, Lowers Price Target to $1.75
BenzingaMar 28, 2023 10:04 ET
No Data